|
|
|
 |
|
|
 |
 |
Sequenom Incorporated
Company
Snapshot Purchase a Full Report on this Company
Business Description:
Sequenom Incorporated. The Group's principal activity is providing genetic analysis products that translate genomic science into superior solutions for non-invasive prenatal testing, biomedical research, molecular medicine and agricultural applications. The Group's proprietary MassARRAY(R) system is a high-performance DNA analysis platform that efficiently and precisely measures the amount of genetic target material and variations therein. The system is able to deliver reliable and specific data from complex biological samples and from genetic target material that is only available in trace amounts. It has exclusively licensed intellectual property rights for the development and commercialization of non-invasive prenatal genetic tests for use with the MassARRAY(R) system and other platforms. It operates in the United States, Germany, United Kingdom, Japan, Hong Kong and India.
|
|
| |
Wright Quality Rating:
CBNN Rating Explanations |
| |
|
| |
|
| |
|
|
|
|
|
|
| |
| |
Stock Data: |
Recent Stock Performance: |
|
| |
Current Price (11/13/2009):
3.27
(Figures in
U.S. Dollars) |
|
1 Week |
1.9% |
|
13 Weeks |
-9.7% |
|
|
|
|
|
|
|
|
|
4 Weeks |
-31.7% |
|
52 Weeks |
-80.5% |
|
|
|
| |
| |
Sequenom Incorporated
Key Data: |
|
|
|
| |
Ticker: |
SQNM |
Country: |
UNITED STATES |
| |
|
| |
Exchanges: |
NAS |
Major Industry: |
Miscellaneous |
| |
|
| |
|
|
Sub Industry: |
Medical Services |
| |
|
| |
2008
Sales |
47,149,000
(Year Ending Jan 2009). |
Employees: |
248 |
| |
|
| |
Currency: |
U.S. Dollars |
Market Cap: |
200,282,278 |
| |
|
| |
Fiscal Yr Ends: |
December |
Shares Outstanding: |
61,248,403 |
| |
|
| |
Share Type: |
Common |
Closely Held Shares: |
11,723,861 |
|
| |
|
| |
| |
|
|
|
|
| |
Purchase a Full Subscription to All Reports From CorporateInformation: |
|
|
|
| |
The following reports, available for Sequenom Incorporated, are typical of the content provided on all companies
covered in CorporateInformation.com
Basic Reports
Sequenom Incorporated company Profile (Business Description, Price/Earnings, Price/Sales,
Price/Book, Dividend Yield, Company Officers, Contact Information), Competitor Analysis and up to ten-year history of Sales, Earnings per Share,
Dividends per Share, Security Price and Key Ratios. View Samples
Financial Statement Reports
Research reports that analyze Sequenom Incorporated Income Statement and Balance Sheet along with
the Sources of Capital for a five-year period. View Samples
Financial Ratio Reports
Analyses reports that highlight Sequenom Incorporated
Accounting Ratios, Asset Utilization, Fixed Charges Coverage, Liquidity, Leverage, Profitability,
Employee Efficiency and Per-Share Data over a five-year period. View Samples
Wright Quality Analyses Reports
Wright’s proprietary rating of corporate quality. The reports include a detailed
analysis of Sequenom Incorporated Equity, Liquidity, Financial Strength,
Profitability and Corporate Growth. View Samples |
| |
|
|
| |
|
|
|
 |
|
|
|
|
|
|
|
CorporateInformation® website and selected data Copyright © 2000 -
by The Winthrop Corporation. All Rights Reserved. Except for quotations by established
news media, no pages on this site may be reproduced, stored in a retrieval system,
or transmitted for commercial purposes, in any form or by any means, electronic,
mechanical, photocopying, recording, or otherwise without prior written permission.
Information is believed reliable, but accuracy, completeness and opinions are not
guaranteed.
|
|
|
|